Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiongshao capsule is a traditional Chinese medicine (TCM) hospital preparation developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences. Derived from the classic Xuefu Zhuyu decoction, it is composed of the active components of Chuanxiong rhizome (*Rhizoma Chuanxiong*) and Red peony root (*Radix Paeoniae Rubra*), primarily containing paeoniflorin, ferulic acid, and total phenolic acids. Xiongshao capsule is developed for the prevention of in-stent restenosis and the treatment of coronary heart disease (including acute coronary syndrome and angina pectoris). It exerts therapeutic effects by promoting blood circulation, resolving blood stasis, inhibiting platelet activation, and suppressing inflammatory responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiongshao capsule.